Given its role as a critical transcriptional regulator that limits pre-B cell expansion and promotes pre-B cell differentiation, it is reasonable to assume that IRF4 may function as a tumor suppressor against pre-B cell transformation. The gene discussed is IRF4; the disease is neoplasm.